Description

Dimaril (Glimepiride) Tablets 4 mg. №30

Ingredients:

Each tablet contains 4 mg of glimepiride as the active ingredient.

Mechanism of Action:

Glimepiride stimulates the release of insulin from the pancreas, thereby lowering blood sugar levels in patients with type 2 diabetes mellitus.

Pharmacological Properties:

Glimepiride increases insulin secretion from pancreatic beta cells and enhances peripheral tissue sensitivity to insulin, promoting glucose uptake and utilization.

Indications for Use:

Dimaril tablets are indicated for the treatment of type 2 diabetes mellitus to help regulate blood glucose levels.

Contraindications:

Avoid using Dimaril if you have type 1 diabetes, diabetic ketoacidosis, or a known hypersensitivity to sulfonylureas.

Side Effects:

Common side effects may include hypoglycemia, dizziness, and gastrointestinal disturbances. Severe reactions are rare but may include severe hypoglycemia or allergic reactions.

Usage Instructions:

The usual starting dose is 1-2 mg once daily with breakfast or the first main meal. Dosage adjustments should be based on individual blood glucose levels.

Benefits Compared to Analogues:

Dimaril has shown comparable efficacy to other sulfonylureas in reducing HbA1c levels with a lower risk of hypoglycemia in clinical trials.

Suitable Patient Groups:

Dimaril can be used in adult patients with type 2 diabetes mellitus. Dosage adjustments may be necessary for elderly patients or those with renal impairment.

Storage Conditions and Shelf Life:

Store Dimaril tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use after the specified date.

Packaging Description:

Dimaril tablets are packaged in blister packs of 30 tablets each for convenient and accurate dosing.

Clinical Evidence and Proven Effectiveness:

Studies have demonstrated the efficacy of glimepiride in reducing HbA1c levels in patients with type 2 diabetes. Research published in the Journal of Diabetes Investigation highlighted the positive impact of glimepiride on glycemic control.